Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Stelara

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Stelara was produced by Johnson & Johnson.

AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod

AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod

Johnson’s Stelara (targeting IL-23 and IL-12) and AbbVie’s own ageing market leader Humira. ... Static Physicians Global Assessment [sPGA] 0/1 and Psoriasis Area and Severity Index [PASI] 90) compared to Stelara and Humira and placebo at week 16 and

Drug launches to watch in 2019

Drug launches to watch in 2019 The analysis concentrated on patient-reported outcomes data from two studies that compared risankizumab to J&J’s $4bn-a-year IL-12/IL-23 inhibitor Stelara (ustekinumab) and one against ... The analysis showed that 56% of patients on risankizumab were

J&J earnings top expectations, but feels the squeeze in US

J&J earnings top expectations, but feels the squeeze in US Nevertheless, the company's annual revenues rose almost 7% to $81.6bn, driven up by three rising star performers in particular: psoriasis treatment Stelara, leukaemia drug Imbruvica and multiple myeloma Darzalex.

J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial

J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial Novartis’ Cosentyx can put some of its fast growth in psoriasis down to data showing it was more effective than Johnson &Johnson’s widely-used Stelara, but a new trial has ... In a head-to-head challenge, J&J’s recently approved follow-up to

New data keeps AbbVie’s star pipeline therapies on track

New data keeps AbbVie’s star pipeline therapies on track The analysis concentrated on patient-reported outcomes data from two studies that compared risankizumab to J&J’s $4bn-a-year IL-12/IL-23 inhibitor Stelara (ustekinumab) and one against ... The analysis showed that 56% of patients on risankizumab were

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics